Autopsy report · NCT02867839

Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer

“The number of patients enrolled was much less than expected”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 4 years 4 months before it stopped.
• 29 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Peking University Cancer Hospital & Institute

Sponsor type

University, hospital or other

Conditions

Gastric Cancer

Interventions

Oxaliplatin plus S-1; S-1 only

Participants

29

Sites

15

Countries

China

Trials that died the same way

• Tracking of Lipid Lowering Therapy in Jordan
  “Inadequate enrolling numbers of patients” (79% match in meaning)
• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
  “no enough enrolled patients” (77% match in meaning)
• Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients
  “Hard to enroll expected number of eligible patients.” (75% match in meaning)
• Ethanol Locks for the Treatment of Central Venous Line Infections
  “inability to enroll adequate number of patients” (75% match in meaning)
• Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients
  “small number of patients got recruited” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.